Accutane warning labels ruled as insufficient
Appeals Court Rules that Accutane Warning Labels Were Insufficient
July 27, 2017
An appeals court in New Jersey has ruled that pharmaceutical manufacturer Hoffman-LaRoche and Roche Laboratories did not provide adequate warning about the side effects of its acne medication Accutane.
More than 500 plaintiffs in the Multi-District Litigation (MDL) case allege that they developed inflammatory bowel disease as a side effect of Accutane usage, and that the drug’s maker should have warned them of this risk.
An earlier court had found in favor of the drugmaker, on the grounds that the drug’s labels had mentioned that Accutane was “associated with” bowel disease. But the appeals court overturned that ruling, arguing that “associated with” is too imprecise a phrase, and that the company was obligated to have used more “causal language” in discussing this potentially serious side effect.
The drugmaker has indicated it will file for a further appeal.
If you’ve been harmed by a drug because its warning label was incomplete or unclear, you may be entitled to significant financial compensation. Contact TheLawFirm.com today to find out how we can help you with your case.
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!